AXIM BIOTECHNOLOGIES (AXIM) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 119 248 sessions, October 23, 2025 to October 23, 2026
- Largest daily move
- +63.3% close of August 11, 2026
- 1-year change
- -61.2% closing prices, October 23, 2025 to October 23, 2026
- 1-month change
- -16.2% closing prices, September 23, 2026 to October 23, 2026
Company Description
AXIM BIOTECHNOLOGIES (OTC: AXIM) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.0M.
AXIM has declined 61.2% over the past year. The last closing price was $0.0031.
For FY2023, AXIM BIOTECHNOLOGIES reported revenue of $40K with net income of -$8.1M and diluted earnings per share of -$0.04.
This page collects what Stock Titan holds for AXIM, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
AXIM BIOTECHNOLOGIES (AXIM) closed at $0.0031 on October 23, 2026. Over the past 12 months, the price has lost 61.2%.
AXIM Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
AXIM BIOTECHNOLOGIES has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, management, fda approval. View all AXIM news →
SEC Filings
Financial Highlights
AXIM BIOTECHNOLOGIES generated $40K in revenue in FY2023, operating income reached -$2.8M, and net income was -$8.1M. Diluted earnings per share stood at -$0.04. The company generated -$1.0M in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in AXIM BIOTECHNOLOGIES (AXIM) currently stands at 82.6 thousand shares, down 8.6% from the previous reporting period, representing 0.0% of the float. Since October 2025, short interest has decreased by 89.7%.
Days to Cover History
Days to cover for AXIM BIOTECHNOLOGIES (AXIM) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 47.1%. Across the settlements charted above, it has ranged from 1.0 to 1.9 days.
AXIM Company Profile & Sector Positioning
AXIM BIOTECHNOLOGIES (AXIM) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing AXIM often look at related companies in the same sector, including VACCINEX INC (VCNX), GREY MATTERS HEALTH INC (AGNPF), GALERA THERAPEUTICS INC (GRTX), ENZOLYTICS INC (ENZC), and AYALA PHARMACEUTICALS INC (ADXS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AXIM's relative position within its industry.